The UK Medicines and Healthcare products Regulatory Agency is actively considering the use of “administrative sanctions” as an additional enforcement tool to ensure that entities in the drug and medical device industries comply with the relevant regulations1,2...
Scrip Regulatory Affairs
UK MHRA considers use of administrative sanctions for compliance
21 June 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- UK MHRA consults on consolidated medicines legislation and policy changes
- ABPI, Serious Fraud Office explain enforcement policy on UK Bribery Act and industry code breaches
- FDA, FTC tell STD cure scammers in US to take corrective action
- US FDA issues much-awaited draft guidelines on developing biosimilars
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
